MOLECUBES NV was founded in 2016 by a small team of engineers with a mission to disrupt the preclinical imaging market by developing benchtop-sized CT-, PET- and SPECT-scanners: our so-called ‘cubes’. Six years later almost 100 cubes are installed worldwide. These cubes are now used daily by renowned research institutes and the pharmaceutical industry to support their research in medical therapies and drug development.